Literature DB >> 7332381

Secretory IgA: immune defence pattern in ankylosing spondylitis and klebsiella.

M Calguneri, L Swinburne, R Shinebaum, E M Cooke, V Wright.   

Abstract

Saliva secretory IgA (sIgA), secretory component (SC); serum immunoglobulins (IgG, IgA, IgM), complement (C3, C4), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) were performed in 32 patients with ankylosing spondylitis and 29 normal controls. They were investigated for carriage in the faeces of Klebsiella spp. on 3 occasions over the previous months. Throat swabs and urine were cultured at the same time as immunological estimations were done. 24-hour urine sIgA specimens were studied in 13 patients and 12 normal controls. Significantly raised mean values of saliva sIgA and serum IgG, IgA, C3, and C4 were found in patients with raised values of serum ESR and CRP levels when correlated with controls. Raised values of sIgA in saliva, which is an important factor of the local immune defence mechanism of mucosal surfaces, suggests the presence of an antigenic stimulus from the gastrointestinal system in ankylosing spondylitis during activity of disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7332381      PMCID: PMC1000838          DOI: 10.1136/ard.40.6.600

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  20 in total

1.  Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.

Authors:  T D Kinsella; L Espinoza; F B Vasey
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

Review 2.  Secretory immunoglobulins.

Authors:  T B Thomasi
Journal:  N Engl J Med       Date:  1972-09-07       Impact factor: 91.245

3.  Ankylosing spondylitis and HL-A 27.

Authors:  D A Brewerton; F D Hart; A Nicholls; M Caffrey; D C James; R D Sturrock
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

4.  Secretory gamma-A in normal urine.

Authors:  J Bienenstock; T B Tomasi
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

5.  High association of an HL-A antigen, W27, with ankylosing spondylitis.

Authors:  L Schlosstein; P I Terasaki; R Bluestone; C M Pearson
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Bone and joint changes in paraplegic men.

Authors:  V Wright; R D Catterall; J B Cook
Journal:  Ann Rheum Dis       Date:  1965-09       Impact factor: 19.103

8.  A controlled quantitative study of parotid salivary secretory IgA-globulin in normal adults.

Authors:  C H Oon; J Lee
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

9.  The IgA system in connection with local and systemic immunity.

Authors:  J F Heremans
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

10.  Quantitation of exocrine IgA in human serum in health and disease.

Authors:  R A Thompson; P Asquith
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 5.732

View more
  16 in total

1.  Serum secretory immunoglobulins in ankylosing spondylitis.

Authors:  D Wendling; J M Didier; E Seilles
Journal:  Clin Rheumatol       Date:  1996-11       Impact factor: 2.980

2.  Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis.

Authors:  O Mäki-Ikola; R Hällgren; L Kanerud; N Feltelius; L Knutsson; K Granfors
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

3.  Absence of IgA nephropathy in patients with ankylosing spondylitis.

Authors:  A J Swaak; I Frankfort; R S Menon; J M Pekelharing; O Planten
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

4.  Salivary of blood specimen for evaluation of drug concentration in rheumatoid arthritis.

Authors:  H A Bird; M E Pickup
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

5.  IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.

Authors:  R Vuento; J Eskola; R Leino; S Koskimies; M Viander
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

6.  Serum and secretory IgA immune response to Klebsiella pneumoniae in ankylosing spondylitis.

Authors:  A K Trull; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

7.  IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis.

Authors:  K Granfors; A Toivanen
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

8.  Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritis.

Authors:  K M Sanders; A Hertzman; M R Escobar; B H Littman
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

9.  Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.

Authors:  R Cooper; S M Fraser; R D Sturrock; C G Gemmell
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-21

10.  HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.

Authors:  A Trull; A Ebringer; G Panayi; R Ebringer; D C James
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.